Jonathan Lee
Stock Analyst at Guggenheim
(1.83)
# 2,612
Out of 4,479 analysts
18
Total ratings
40%
Success rate
-4.27%
Average return
Main Sectors:
12 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACN Accenture | Reiterates: Buy | $395 | $302.55 | +30.56% | 2 | May 24, 2024 | |
DAVA Endava | Maintains: Buy | $60 → $55 | $29.10 | +89.00% | 2 | May 24, 2024 | |
TIXT TELUS International (Cda) | Initiates: Neutral | $9 | $5.89 | +52.80% | 1 | Mar 19, 2024 | |
DXC DXC Technology Company | Initiates: Neutral | $22 | $18.62 | +18.15% | 1 | Mar 19, 2024 | |
CTSH Cognizant Technology Solutions | Initiates: Neutral | $80 | $67.74 | +18.10% | 1 | Mar 19, 2024 | |
TASK TaskUs | Initiates: Neutral | $13 | $13.30 | -2.26% | 1 | Mar 19, 2024 | |
EPAM EPAM Systems | Initiates: Buy | $350 | $185.58 | +88.60% | 1 | Mar 19, 2024 | |
GLOB Globant | Initiates: Buy | $250 | $176.29 | +41.81% | 1 | Mar 19, 2024 | |
INFY Infosys | Initiates: Neutral | $20 | $18.76 | +6.61% | 1 | Mar 19, 2024 | |
PRFT Perficient | Initiates: Neutral | $65 | $74.80 | -13.10% | 5 | Mar 19, 2024 | |
TTEC TTEC Holdings | Initiates: Sell | $8 | $5.75 | +39.13% | 1 | Mar 19, 2024 | |
PTCT PTC Therapeutics | Maintains: Equal-Weight | $54 → $40 | $31.17 | +28.33% | 1 | Oct 28, 2022 |
Accenture
May 24, 2024
Reiterates: Buy
Price Target: $395
Current: $302.55
Upside: +30.56%
Endava
May 24, 2024
Maintains: Buy
Price Target: $60 → $55
Current: $29.10
Upside: +89.00%
TELUS International (Cda)
Mar 19, 2024
Initiates: Neutral
Price Target: $9
Current: $5.89
Upside: +52.80%
DXC Technology Company
Mar 19, 2024
Initiates: Neutral
Price Target: $22
Current: $18.62
Upside: +18.15%
Cognizant Technology Solutions
Mar 19, 2024
Initiates: Neutral
Price Target: $80
Current: $67.74
Upside: +18.10%
TaskUs
Mar 19, 2024
Initiates: Neutral
Price Target: $13
Current: $13.30
Upside: -2.26%
EPAM Systems
Mar 19, 2024
Initiates: Buy
Price Target: $350
Current: $185.58
Upside: +88.60%
Globant
Mar 19, 2024
Initiates: Buy
Price Target: $250
Current: $176.29
Upside: +41.81%
Infosys
Mar 19, 2024
Initiates: Neutral
Price Target: $20
Current: $18.76
Upside: +6.61%
Perficient
Mar 19, 2024
Initiates: Neutral
Price Target: $65
Current: $74.80
Upside: -13.10%
TTEC Holdings
Mar 19, 2024
Initiates: Sell
Price Target: $8
Current: $5.75
Upside: +39.13%
PTC Therapeutics
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $54 → $40
Current: $31.17
Upside: +28.33%